147 related articles for article (PubMed ID: 28210822)
1. Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.
Ding K; Chen X; Wang Y; Liu H; Song W; Li L; Wang G; Song J; Shao Z; Fu R
Int J Clin Oncol; 2017 Jun; 22(3):585-592. PubMed ID: 28210822
[TBL] [Abstract][Full Text] [Related]
2. [Plasma DNA methylation of shp1 in patients with diffuse large B cell lymphoma].
Chen X; Fu R; Wang Y; Song W; Ruan E; Qu W; Wang H; Wang G; Song J; Wang X; Wu Y; Xing L; Liu H; Li L; Guan J; Shao Z
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1071-5. PubMed ID: 24851890
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
4. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
Koyama M; Oka T; Ouchida M; Nakatani Y; Nishiuchi R; Yoshino T; Hayashi K; Akagi T; Seino Y
Lab Invest; 2003 Dec; 83(12):1849-58. PubMed ID: 14691303
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
[TBL] [Abstract][Full Text] [Related]
6. Advanced rai stage in patients with chronic lymphocytic leukaemia correlates with simultaneous hypermethylation of plural tumour suppressor genes.
Forsterová K; Votavová H; Schwarz J; Karban J; Stuka C; Trněný M
Folia Biol (Praha); 2010; 56(4):158-64. PubMed ID: 20974048
[TBL] [Abstract][Full Text] [Related]
7. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group.
Shiozawa E; Takimoto M; Makino R; Adachi D; Saito B; Yamochi-Onizuka T; Yamochi T; Shimozuma J; Maeda T; Kohno Y; Kawakami K; Nakamaki T; Tomoyasu S; Shiokawa A; Ota H
Leuk Res; 2006 Jul; 30(7):859-67. PubMed ID: 16406514
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.
Zainuddin N; Kanduri M; Berglund M; Lindell M; Amini RM; Roos G; Sundström C; Enblad G; Rosenquist R
Leuk Res; 2011 Apr; 35(4):438-43. PubMed ID: 21035853
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
[TBL] [Abstract][Full Text] [Related]
12. Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm.
Yang JJ; Chen H; Zheng XQ; Li HY; Wu JB; Tang LY; Gao SM
Asian Pac J Cancer Prev; 2015; 16(6):2219-25. PubMed ID: 25824741
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
14. Analyses of P16
Jurisic V; Obradovic J; Nikolic N; Javorac J; Perin B; Milasin J
Mol Biol Rep; 2023 Feb; 50(2):971-979. PubMed ID: 36378420
[TBL] [Abstract][Full Text] [Related]
15. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
16. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].
Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081
[TBL] [Abstract][Full Text] [Related]
17. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients.
Gonçalves AC; Cortesão E; Oliveiros B; Alves V; Espadana AI; Rito L; Magalhães E; Pereira S; Pereira A; Costa JM; Mota-Vieira L; Sarmento-Ribeiro AB
Clin Exp Med; 2016 Aug; 16(3):333-43. PubMed ID: 25982567
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer.
Guo L; Huang C; Ji QJ
Bratisl Lek Listy; 2017; 118(3):164-168. PubMed ID: 28319413
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
